Credit should go to Sun Pictures, Karthik Subbaraj:Rajinikanth on 'Petta'
- Country:
- India
Tamil superstar Rajinikanth has expressed "happiness"
that "Petta" is being received warmly by the fans and has credited the director for getting the best out of him.
The superstar, who arrived here Thursday after a brief stay in the United States, was addressing reporters at his residence.
"First, I express my new year and Pongal wishes to one and all. I came to know that the movie is liked by everyone. Very happy for that. The credits should go to Sun Pictures (film producer), Karthik Subbaraj (director) and his unit," Rajinikanth said.
The superstar said as an actor, his utmost priority is that his films should deliver on the expectations of his fans.
"My job is to make them happy. That is very important. I am happy that they are happy. As I said earlier, the credits should go to Karthik Subbaraj. He made sure that he got the best from me in every shot, every scene."
"Petta" hit screens worldwide amid much fanfare Thursday with two couples choosing the occasion to tie the knot.
Elated fans danced to drumbeats and poured milk on huge cuts-out of the 69-year-old actor outside theatres across the state, which has become something of a tradition with all Rajinikanth releases.
Produced by Sun Pictures, the music is scored by Anirudh.
The film's cast also includes Nawazuddin Siddiqui, Vijay Sethupathy, Simran, Trisha and actor-director Sasikumar.
"Petta", roughly translating into one's local stronghold in Tamil, released along with Ajith Nayanthara-starrer "Viswasam".
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
ALSO READ
Hong Kong denies entry to Reporters Without Borders' representative in latest blow to press freedoms
FACTBOX-How Elon Musk's pay package compares to other top CEOs in United States
Janhvi Kapoor's ‘Ulajh’ to release in theatres on July 5
Top medal contenders at the Paris Olympics: United States and China predicted to dominate
Zydus Lifesciences introduces generic treatment for overactive bladder in the United States